[1]孟 俊a,顾志冬a,陈呢喃b,等.视黄醇结合蛋白4检测在营养性疾病 及肝肾损害检测中的临床应用[J].现代检验医学杂志,2015,30(01):1-3.[doi:10.3969/j.issn.1671-7414.2015.01.001]
 MENG Juna,GU Zhi-donga,CHEN Ninanb,et al.Assessment of Retinol Binding Protein 4 in Nutritional Diseases and Liver or Kidney Diseases[J].Journal of Modern Laboratory Medicine,2015,30(01):1-3.[doi:10.3969/j.issn.1671-7414.2015.01.001]
点击复制

视黄醇结合蛋白4检测在营养性疾病 及肝肾损害检测中的临床应用()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年01期
页码:
1-3
栏目:
述评
出版日期:
2015-01-30

文章信息/Info

Title:
Assessment of Retinol Binding Protein 4 in Nutritional Diseases and Liver or Kidney Diseases
文章编号:
1671-7414(2015)01-001-04
作者:
孟 俊a顾志冬a陈呢喃b张冬青b
上海交通大学医学院a.附属瑞金医院检验科;
b.上海市免疫学研究所,上海 200025
Author(s):
MENG JunaGU Zhi-dongaCHEN NinanbZHANG Dong-qingb
a.Department of Clinical Laboratory,Ruijin Hospital;
b.Shanghai Institute of Immunology, Medical School of Shanghai Jiaotong University,Shanghai 200025,China
关键词:
视黄醇结合蛋白4 营养性疾病 肝肾损害
分类号:
R531.3; R381
DOI:
10.3969/j.issn.1671-7414.2015.01.001
文献标志码:
A
摘要:
视黄醇结合蛋白(retinol binding protein,RBP)是一种分泌型视黄醇结合蛋白,主要合成于肝脏,广泛分布于人体血液、尿液等体液中的视黄醇(VitA)运载蛋白,在协助VitA发挥生理功能中起到关键作用
[1]
。最新研究表明:RBP4是一种新的脂肪细胞因子,参与胰岛素抵抗和2型糖尿病的发生,与糖尿病肾病、营养性疾病等的发展存在着一定的相关性。这一发现使得RBP4更加受到人们的重视。该文就RBP4的生理功能,在肝肾疾病、糖尿病等各类疾病方面的应用以及新型临床检测方法作一综述。
Abstract:
Retinol binding protein 4(RBP4)was a class ofsecreting protein,mainly synthesized by the liver,widely distributed in the human body blood,urine and other body fluids.It plays an important role in assisting the physiological function of vitamin A
[1]
.Recent research shows that RBP4 was a new kind of adipocytokine,participated in insulin resistance andoccurrence of type 2 diabetes,and had a closed relationship with diabetic nephropathy,nutritional disease.This article describes the function of RBP4,review the relationship between RBP4 and nutritional or other type of diseases,and new clinical detection method with RBP4.

参考文献/References:

[1] 郭晓红,储明星,周忠孝.视黄醇结合蛋白及其基因的分子生物学[J].遗传,2004,26(2):257-262. Guo XH,Chu MX,Zhou ZX.Progress retinol-binding protein and theirgene[J].Hereditary,2004,26(2):257-262.
[2] Yang Q,Graham TE,Mody N,et al.Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J].Nature,2005,436(7049):356-362.
[3] 彭彦梦,孟家和,周度金,等.视黄醇结合蛋白的研究进展[J].国际检验医学杂志,2007,28(8):736-737,740. Peng YM,Meng JH,Zhou DJ,et al.Research Progress of retinol-binding protein[J].International Journal of Laboratory Medicine,2007,28(8):736-737,740.
[4] 贾伟平.视黄醇结合蛋白4与糖尿病[J].临床内科杂志,2008,25(3):155-157. Jia WP.Retinol-binding protein 4 and diabetes[J].Journal of Clinical Internal Medicine,2008,25(3):155-157.
[5] Blumsohn A,Mrris BM,Griffiths H,et al.Stability of β2-microglobulinand retinol-binding protein at different values of pH and temperature in normal and pathological urine[J].Clini Chimi Acta,1990,195(3):133-137.
[6] 成海恩,高 嵩,吴先国,等.血清视黄醇结合蛋白与尿素、肌酐及半胱氨酸蛋白酶抑制剂C的相关性探讨[J].检验医学,2010,25(7):567-568. Cheng HE,Gao S,Wu XG,et al.Correlation of Serum Retinol-BindingProtein,Urea,Creatinine and Cystatin C[J].Lab Med,2010,25(7):567-568.
[7] Kawaguchi R,Yu JM,Wiita P,et al.An essential ligand-binding domain in the membrane receptor for retinol-binding protein revealed by large-scale mutagenesis and a human polymorphism[J].Journal of Biological Chemistry,2008,283(22):15160-15168.
[8] Alkhouri N,Lopez R,Berk M,et al.Serum retinol-binding protein 4(RBP4)levels in patients with nonalcoholic fatty liver disease[J].J Clin Gastroenterol,2009,43(10):985-989.
[9] Romanowska A,Lebensztejn DM,Skiba E,et al.Retinol binding protein-4as a serum biomarker of intrahepatic lipid content in obese children-preliminary report[J].Acta Biochim Pol,2011,58(1):35-38.
[10] Graham TE,Yang Q,Blüher M,et al.Retinol-binding protein 4and insulin resistance in lean,obese,and diabetic subjects[J].N Engl J Med,2006,354(24):2552-6253.
[11] Esteve E,Ricart W,Fernández-Real JM.Adipocytokines and insulin resistance:the possible role of lipocalin-2,retinol binding protein-4,and adiponectin[J].Diabetes Care,2009,32(Suppl 2):S362-367.
[12] Henze A,Frey SK,Raila J,et al.Evidence that kidney function but nottype 2 diabetes determines retinol-binding protein 4 serum levels[J].Diabetes,2008,57(12):3323-3326.
[13] Murata M,Saito T,Otani T,et al.An increase in serum retinol-bindingprotein 4 in the type 2 diabetic subjects with nephropathy[J].Endocr J.2009,56(2):287-294.
[14] Chavez AO,Coletta DK,Kamath S,et al.Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans[J].Am J Physiol Endocrinol Metab,2009,296(4):758-764.
[15] Shim CY,Park S,Kim JS,et al.Association of plasma retinol-binding protein 4,adiponectin,and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients[J].Yonsei Med J,2010,51(3):375-384.
[16] Ribel-Madsen R,Friedrichsen M,Vaag A,et al.Regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action[J].Diabetes,2009,58(1):54-60.
[17] 葛青玮.视黄醇结合蛋白、前白蛋白在新生儿营养评价中的意义.检验医学[J].2007,22(2):198-199.Ge QW.The significance of retinol binding protein and prealbuminin the neonatal nutritional evaluation[J].Lab Med,2007,22(2):198-199.
[18] 郑雪莲,李玉珍,朱 刚,等.血清前白蛋白、转铁蛋白及视黄醇结合蛋白在危重病人应用肠外营养支持中的意义[J].海南医学,2009,20(5):278-279. Zheng XL,Li YZ,Zhu G,et al.Significance of serum prealbumin,transferrin,and retinol binding protein in the critical patients with parenteral nutrition support[J].Hainan Medical Journal,2009,20(5):278-279.
[19] Rhie YJ,Choi BM,Eun SH,et al.Association of serum retinol binding protein 4 with adiposity and pubertal development in korean children and adolescents[J].J Korean Med Sci,2011,26(6):797-802.
[20] Park CS,Ihm SH,Park HJ,et al.Relationship between plasma adiponectin,retinol-binding protein 4 and uric acid in hypertensive patients with metabolic syndrome[J].Korean Circ J,2011,41(4):198-202.
[21] 蔡晔芬,黄清松.免疫透射比浊法测定视黄醇结合蛋白的技术性能评价[J].宜春学院学报,2011,33(4):74-75. Cai YF,Huang QS.Performance evaluation of immune transmission turbidityfor retinol binding protein[J].Journal of Yichun College,2011,33(4):74-75.

相似文献/References:

[1]于彩霞,巩云霏,闫 苏,等.血清视黄醇结合蛋白4 及骨桥蛋白与绝经后骨质疏松症的相关性研究[J].现代检验医学杂志,2020,35(02):112.[doi:10.3969 / j.issn.1671-7414.2020.02.031]
 YU Cai-xia,GONG Yun-fei,YAN Su,et al.Relationship between Serum Retinol Binding Protein 4 and Osteopontin andPostmenopausal Osteoporosis[J].Journal of Modern Laboratory Medicine,2020,35(01):112.[doi:10.3969 / j.issn.1671-7414.2020.02.031]

备注/Memo

备注/Memo:
基金项目:本课题系国家自然科学基金面上项目(31270963); 上海市科委重点连续资助项目(10JC1408500); 上海市科委生物医药领域科技支撑项目2014年度“科技创新行动计划”项目(14431903700); 上海交通大学医学院附属瑞金医院优青项目(8003)。
作者简介:孟 俊(1982-),男,在读硕士,主管技师,研究方向:免疫学相关检测,E-mail:mjun2004@126.com。
通讯作者:张冬青,E-mail:dqzhang1333@163.com。
更新日期/Last Update: 2015-01-30